[Pharmacotherapy of depression in patients with and without conversion from depression to mania in the course of bipolar affective disorder].
To answer the question whether the kind and duration of the applied antidepressant therapy is a risk factor for the occurrence of mania directly after depression, the treatment of depression relapses in 30 patients with switch from depression to mania in the course of bipolar disease, and the treatment of 30 (appropriately selected) patients without this change was compared. No differences in treatment procedures were stated in comparable relapses, apart from more frequent application of lithium carbonate and carbamazepine in the patients with the switch from depression to mania. It was shown that long-term application of antidepressant drugs is not connected with the increased risk of such change.
Koszewska
I
I
Z II Kliniki Psychiatrycznej IPiN w Warszawie.
D000328:Adult; D000368:Aged; D000929:Antidepressive Agents, Tricyclic / Q000627:therapeutic use*; D014150:Antipsychotic Agents / Q000627:therapeutic use*; D001714:Bipolar Disorder / Q000188:drug therapy* / Q000523:psychology; D003866:Depressive Disorder / Q000188:drug therapy* / Q000523:psychology*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies
D000929:Antidepressive Agents, Tricyclic; D014150:Antipsychotic Agents
Farmakoterapia nawrotów depresyjnych u chorych ze zmiana fazy depresyjnej w maniakalna i bez zmiany fazy w przebiegu choroby afektywnej dwubiegunowej.